Enteral Nutrition

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
2 programs
ProvideXtra DRINKN/A1 trial
SupportanN/A1 trial
Active Trials
NCT00600678Completed12Est. Jan 2008
NCT01025167Completed111Est. Jan 2010
Providence Therapeutics
1 program
Nasal bridle securement device for small bore feeding tubesN/A1 trial
Active Trials
NCT03387358UnknownEst. Feb 2019
Abbott
AbbottABBOTT PARK, IL
1 program
Nutraflora scFOSN/A1 trial
Active Trials
NCT03153397Completed20Est. May 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Providence TherapeuticsNasal bridle securement device for small bore feeding tubes
AbbottNutraflora scFOS
Fresenius KabiProvideXtra DRINK
Fresenius KabiSupportan

Clinical Trials (4)

Total enrollment: 143 patients across 4 trials

NCT03387358Providence TherapeuticsNasal bridle securement device for small bore feeding tubes

An Observational Study Examining Adverse Events and Effectiveness of the Nasal Bridle Securement Device in ICU Patients

Start: Apr 2018Est. completion: Feb 2019
N/AUnknown
NCT03153397AbbottNutraflora scFOS

Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)

Start: Oct 2017Est. completion: May 202120 patients
N/ACompleted
NCT00600678Fresenius KabiProvideXtra DRINK

Gastric Emptying Study After Administration of a High Caloric Sip Feed

Start: Nov 2007Est. completion: Jan 200812 patients
N/ACompleted

The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients

Start: Sep 2006Est. completion: Jan 2010111 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space